These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 11015199)

  • 1. Structure-based optimization of peptide inhibitors of mammalian ribonucleotide reductase.
    Pellegrini M; Liehr S; Fisher AL; Laub PB; Cooperman BS; Mierke DF
    Biochemistry; 2000 Oct; 39(40):12210-5. PubMed ID: 11015199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. More potent linear peptide inhibitors of mammalian ribonucleotide reductase.
    Tan C; Gao Y; Kaur J; Cooperman BS
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5301-4. PubMed ID: 15454215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of action of peptide inhibitors of mammalian ribonucleotide reductase targeting quaternary structure.
    Gao Y; Kashlan OB; Kaur J; Tan C; Cooperman BS
    Biopolymers; 2005; 80(1):9-17. PubMed ID: 15586357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptide inhibitors of mammalian ribonucleotide reductase.
    Cooperman BS; Gao Y; Tan C; Kashlan OB; Kaur J
    Adv Enzyme Regul; 2005; 45():112-25. PubMed ID: 16054677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological activity of cyclic peptide inhibitors of ribonucleotide reductase.
    Liehr S; Barbosa J; Smith AB; Cooperman BS
    Org Lett; 1999 Oct; 1(8):1201-4. PubMed ID: 10825970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward a rational design of peptide inhibitors of ribonucleotide reductase: structure-function and modeling studies.
    Pender BA; Wu X; Axelsen PH; Cooperman BS
    J Med Chem; 2001 Jan; 44(1):36-46. PubMed ID: 11141086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chimeric small subunit inhibitors of mammalian ribonucleotide reductase: a dual function for the R2 C-terminus?
    Hamann CS; Lentainge S; Li LS; Salem JS; Yang FD; Cooperman BS
    Protein Eng; 1998 Mar; 11(3):219-24. PubMed ID: 9613846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequencing cyclic peptide inhibitors of mammalian ribonucleotide reductase by electrospray ionization mass spectrometry.
    Lin S; Liehr S; Cooperman BS; Cotter RJ
    J Mass Spectrom; 2001 Jun; 36(6):658-63. PubMed ID: 11433539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affinity-driven selection of tripeptide inhibitors of ribonucleotide reductase.
    Gao Y; Liehr S; Cooperman BS
    Bioorg Med Chem Lett; 2002 Feb; 12(4):513-5. PubMed ID: 11844661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design and synthesis of a tetrahydropyran-based inhibitor of mammalian ribonucleotide reductase.
    Smith AB; Sasho S; Barwis BA; Sprengeler P; Barbosa J; Hirschmann R; Cooperman BS
    Bioorg Med Chem Lett; 1998 Nov; 8(22):3133-6. PubMed ID: 9873690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ureido-based peptidomimetic inhibitor of herpes simplex virus ribonucleotide reductase: an investigation of inhibitor bioactive conformation.
    Moss N; Beaulieu P; Duceppe JS; Ferland JM; Gauthier J; Ghiro E; Goulet S; Guse I; Llinàs-Brunet M; Plante R; Plamondon L; Wernic D; Déziel R
    J Med Chem; 1996 May; 39(11):2178-87. PubMed ID: 8667361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The structural basis for peptidomimetic inhibition of eukaryotic ribonucleotide reductase: a conformationally flexible pharmacophore.
    Xu H; Fairman JW; Wijerathna SR; Kreischer NR; LaMacchia J; Helmbrecht E; Cooperman BS; Dealwis C
    J Med Chem; 2008 Aug; 51(15):4653-9. PubMed ID: 18610997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive model for allosteric regulation of mammalian ribonucleotide reductase: refinements and consequences.
    Kashlan OB; Cooperman BS
    Biochemistry; 2003 Feb; 42(6):1696-706. PubMed ID: 12578384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. R2 C-terminal peptide inhibition of mammalian and yeast ribonucleotide reductase.
    Fisher A; Yang FD; Rubin H; Cooperman BS
    J Med Chem; 1993 Nov; 36(24):3859-62. PubMed ID: 8254617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligopeptide inhibition of class I ribonucleotide reductases.
    Cooperman BS
    Biopolymers; 2003; 71(2):117-31. PubMed ID: 12767114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for the activity of pp60(c-src) protein tyrosine kinase inhibitors.
    Prabhu NV; Siddiqui SA; McMurray JS; Pettitt BM
    Biopolymers; 2001 Sep; 59(3):167-79. PubMed ID: 11391566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NMR structure of an inhibitory R2 C-terminal peptide bound to mouse ribonucleotide reductase R1 subunit.
    Fisher A; Laub PB; Cooperman BS
    Nat Struct Biol; 1995 Nov; 2(11):951-5. PubMed ID: 7583667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological activity of a bivalent nucleotide inhibitor of ribonucleotide reductase.
    Wu X; Cooperman BS
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2387-9. PubMed ID: 11055362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive model for the allosteric regulation of mammalian ribonucleotide reductase. Functional consequences of ATP- and dATP-induced oligomerization of the large subunit.
    Kashlan OB; Scott CP; Lear JD; Cooperman BS
    Biochemistry; 2002 Jan; 41(2):462-74. PubMed ID: 11781084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of small peptides mimicking the R2 C-terminus of Mycobacterium tuberculosis ribonucleotide reductase.
    Ericsson DJ; Nurbo J; Muthas D; Hertzberg K; Lindeberg G; Karlén A; Unge T
    J Pept Sci; 2010 Mar; 16(3):159-64. PubMed ID: 20127854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.